Genomic Solutions Reports Higher Revenues; Predicts Profitability by Yearend | GenomeWeb

NEW YORK, Feb 15 – Genomic Solutions reported Thursday fourth quarter 2000 earnings of $5.5 million, up from $3.4 million in the same quarter of 1999, as the result of increased sales of the Investigator proteomic and GeneTAC biochip system and revenues from contract research performed at the company’s Proteomic Research Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.